F42K, a mutant IL-2, induced a systematic decrease in the expansion of ICOS+ Treg cells, which promoted the expansion of NK cells and inhibited the tumor growth of melanoma more efficiently than wild-type IL-2 [370]. The gene discussed is IL2; the disease is melanoma.